Afshin Dowlati, Raffaele Califano, Koichi Goto, Maurice Pérol, Yi-Long Wu, Ralph V. Boccia, Paul A. S. Fishkin, John Turner Hamm, Benjamin Jacobs, Melissa Lynne Johnson, Gopal Kunta, Santosh Nair, Manish R. Patel, Caleb Joshua Smith, Yifan Tu, Jun Zhang, Pingkuan Zhang, Renke Zhou, Luis Paz-Ares Rodríguez. "A randomized, open-label, phase 3 study of ZL-1310, a DLL3 antibody-drug conjugate (ADC), compared to investigator’s choice therapy in participants with relapsed small cell lung cancer (DLLEVATE).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8136